Department of Neurobiology, College of Basic Medicine, China Medical University, Shenyang, Liaoning, China (mainland).
Department of Neurosurgery, Shengjing Hospital, China Medical University, Shenyang, Liaoning, China (mainland).
Med Sci Monit. 2014 Dec 7;20:2571-7. doi: 10.12659/MSM.892994.
The aim of this study was to determine whether miR-210 can affect the apoptosis and proliferation of human U251 glioma cells from down-regulating SIN3A.
The expression of miRNA-210 was detected by quantitative real-time PCR in normal brain tissue and glioma samples. The apoptosis and proliferation ability of U251 cells were analyzed by MTT and flow cytometry assay after anti-miR-210 transfection. For the regulation mechanism analysis of miR-210, TargetScan, PicTar, and microRNA were selected to predict some potential target genes of miR-210. The predicted gene was identified to be the direct and specific target gene of miR-210 by luciferase activities assay and Western blot. RNA interference technology was used to confirm that the apoptosis and proliferation effects of miR-210 were directly induced by SIN3A.
The expression of miR-210 increased significantly in glioma in comparison with normal brain tissue. The silence of miR-210 expression could inhibit the proliferation of U251 cells and induce the apoptosis. Mechanism analysis revealed that SIN3A was a specific and direct target gene of miR-210. The siRNA-SIN3A could down-regulate the expression of SIN3A protein, which was up-regulated in U251 cells by anti-miR-210 transfection, and our experiments found that silence of SIN3A could inhibit the apoptosis and sharply increase the proliferation of U251 cells. The regulation effects of anti-miR-210 on apoptosis and proliferation can be reversed respectively by the expression silence of SIN3A.
Aberrantly expressed miR-210 regulates human U251 glioma cells apoptosis and proliferation partly through directly down-regulating SIN3A protein expression. This might offer a new potential therapeutic stratagem for glioma.
本研究旨在通过下调 SIN3A 来确定 miR-210 是否能够影响人 U251 神经胶质瘤细胞的凋亡和增殖。
通过定量实时 PCR 检测正常脑组织和胶质瘤样本中 miRNA-210 的表达。转染抗 miR-210 后,通过 MTT 和流式细胞术分析 U251 细胞的凋亡和增殖能力。为了分析 miR-210 的调节机制,选择了 TargetScan、PicTar 和 microRNA 来预测 miR-210 的一些潜在靶基因。通过荧光素酶活性测定和 Western blot 鉴定该预测基因是 miR-210 的直接和特异靶基因。利用 RNA 干扰技术证实 miR-210 的凋亡和增殖作用是通过 SIN3A 直接诱导的。
与正常脑组织相比,miR-210 在胶质瘤中的表达显著增加。沉默 miR-210 表达可抑制 U251 细胞的增殖并诱导其凋亡。机制分析表明,SIN3A 是 miR-210 的特异性直接靶基因。siRNA-SIN3A 可下调 U251 细胞中由抗 miR-210 转染而上调的 SIN3A 蛋白表达,我们的实验发现沉默 SIN3A 可抑制 U251 细胞的凋亡并显著增加其增殖。SIN3A 的表达沉默可分别逆转抗 miR-210 对凋亡和增殖的调节作用。
异常表达的 miR-210 部分通过直接下调 SIN3A 蛋白表达来调节人 U251 神经胶质瘤细胞的凋亡和增殖。这可能为神经胶质瘤提供一种新的潜在治疗策略。